Search

everythinglearnresearchcommunity

for

Search:↓

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Rituximab can cause skin issues, but baricitinib may help improve them.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Alopecia areata treatments often don't lead to lasting improvement.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Oral betamethasone mini-pulses effectively treat moderate to severe alopecia areata with manageable side effects.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Baricitinib treatment for severe alopecia areata shows significant improvement by 52 weeks, especially in very severe cases.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.